Reading Time: < 1 minute
Omega Diagnostics Group PLC on Monday said it CE-marked its VISITECT CD4 Advanced Disease test for monitoring people living with HIV.
The company said that the technical file supporting the CE-Mark will form the basis of the additional regulatory approvals that it will seek through the UNITAID-funded Expert Review Panel for Diagnostics hosted by the Global Fund to Fight AIDS, Tuberculosis and Malaria. Read More